Clinical Trials Logo

Aortic Valve Calcification clinical trials

View clinical trials related to Aortic Valve Calcification.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06192706 Active, not recruiting - Clinical trials for Aortic Valve Stenosis

Clinical Investigation for the Foldax Tria Aortic Heart Valve- India

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to conduct a clinical investigation of the Foldax Tria Aortic Valve to collect evidence on the device's safety and performance.

NCT ID: NCT05712161 Active, not recruiting - Aortic Stenosis Clinical Trials

Use of DurAVR™ THV System in Subjects With Severe Aortic Stenosis: Early Feasibility Study

DurAVR™ EFS
Start date: August 7, 2023
Phase: N/A
Study type: Interventional

To evaluate the safety and feasibility of DurAVR™ THV System in the treatment of subjects with symptomatic severe native aortic stenosis.

NCT ID: NCT05235568 Active, not recruiting - Clinical trials for Aortic Valve Stenosis

VALVOSOFT® Pivotal Study

Start date: June 15, 2022
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the safety and performance of a new non-invasive ultrasound therapy (NIUT) with Valvosoft in the treatment of Calified Aortic Stenosis

NCT ID: NCT05182307 Active, not recruiting - Clinical trials for Symptomatic Aortic Stenosis

DurAVR™ THV System: First-In-Human Study

Start date: November 15, 2021
Phase: N/A
Study type: Interventional

A prospective, non-randomized, single-arm, single-center, first-in-human study designed to evaluate the safety and feasibility of the DurAVR™ THV System in the treatment of subjects with symptomatic severe aortic stenosis.

NCT ID: NCT04655248 Active, not recruiting - Clinical trials for Aortic Valve Stenosis

ACURATE neo2™ Post Market Clinical Follow up Study

Start date: December 16, 2020
Phase:
Study type: Observational

The ACURATE Neo2 PMCF is aimed at collecting clinical and device performance outcomes data with the ACURATE neo2™ Transfemoral Aortic Valve System as used in routine clinical practice for the treatment of severe calcific aortic stenosis.